Stock Taper Consolidated Net Sales: Increased 21% year-over-year to $66.7 million.
Net Income: $10.8 million, or $0.09 per share, up from a net loss of $800,000 in Q3 2024.
Adjusted EBITDA: Rose to $20.7 million, a significant increase from $4.7 million year-over-year, resulting in an adjusted EBITDA margin of 31%.
Cash Flow from Operations: Reached a record $24.4 million, up from $6.1 million in Q3 2024.
Canadian Cannabis Segment: Net sales of $64.1 million, a 29% increase year-over-year, with a gross margin of 56%, significantly above the targeted range of 30-40%.
The Canadian cannabis business experienced strong growth driven by improved pricing and a shift towards higher-margin products.
International medical cannabis exports surged by 758% year-over-year, with Germany identified as a key growth market.
The company is expanding production capacity in Canada, with a 40 metric ton capacity expansion project underway, expected to be operational by Q2 2026.
In The Netherlands, the first facility reached full production capacity, with plans for a second facility to increase production fivefold by late Q1 2026.
A share repurchase program of $10 million was initiated, reflecting confidence in the company’s financial strength.
Management expressed optimism about continued growth in revenue and EBITDA, supported by operational expertise and cost discipline.
The company anticipates that the expansion of production capacity will further enhance its market position and profitability in both Canadian and international markets.
The management remains committed to maintaining gross margins in the targeted range of 30-40% over the long term.
The U.S. cannabis segment reported stagnant sales of $3.3 million, reflecting regulatory challenges and competition from unregulated hemp products.
While the company is optimistic about growth, it acknowledged potential market volatility and the need for continuous operational excellence to maintain competitive advantages.
The competitive landscape in the Netherlands is evolving, with some peers facing operational challenges, which could impact market dynamics.
Gross Margin Discussion: Management highlighted improved efficiency, higher crop yields, and favorable pricing as key drivers of the strong gross margin. They reaffirmed their long-term target of 30-40%.
International Market Position: The CEO indicated confidence in being a leading exporter to Europe, particularly Germany, while noting that the company has avoided risky markets like Portugal.
Texas Market Potential: Management is cautiously optimistic about the Texas market, anticipating new licenses and regulatory improvements, while maintaining a strategic approach to potential M&A opportunities.
Quebec Market Dynamics: While Quebec is important, it does not constitute 40% of revenues as previously thought. Regulatory changes, particularly regarding vape products, are expected to enhance market opportunities. Overall, Village Farms International reported a strong quarter with record financial metrics, strategic growth initiatives, and a positive outlook, despite facing challenges in certain segments and competitive pressures.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT